Get a head start on securing your place in development of precision medicines and associated diagnostics by downloading Nine Tips for Success in Precision Medicine: Concise Guidance for Biopharma and Diagnostics Developers.
All signs point to a rapid transition to precision medicine. More than 1 in 4 new drugs approved by FDA in 2015 were precision medicines as are 42% of drugs in the pipeline. However, challenges vary by therapeutic area and indication. Securing your place in precision medicine requires staying abreast of evolving developments in areas including biomarker identification and validation, identifying subgroups in target populations, collecting evidence of clinical utility and regulatory policy for LDTs and other companion diagnostics. This white paper provides nine tips for success as precision medicine ceases to be the exception in drug and diagnostics development and becomes the rule.
Download this white paper for tips on nine areas essential to success in the rapidly evolving field of precision medicine.
First Name *
Last Name *
District of Columbia
Job Title *
Phone Number *
numerals only please